NCT02121535 - Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Healthy

Interventions

DRUG

T80/A5 mg FDC tablet

DRUG

T80/A5 mg FDC tablet

A Telmisartan 80 mg/ Amlodipine 5 mg FDC tablet

DRUG

H12.5 mg tablet

DRUG

T80/A5/H12.5 ng FDC tablet

A Telmisartan 80 mg/Amlodipine 5 mg/HCTZ 12.5 mg FDC tablet

DRUG

H12.5 mf tablet

A HCTZ 12.5 mg tablet

DRUG

T80/A5/H12.5 mg FDC tablet

Trial Locations (1)

Boehringer Ingelheim Investigational Site, Kanagawa, Yokohama